1. Home
  2. VERU vs INDO Comparison

VERU vs INDO Comparison

Compare VERU & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

SELL

Current Price

$2.92

Market Cap

48.2M

Sector

Health Care

ML Signal

SELL

Logo Indonesia Energy Corporation Limited

INDO

Indonesia Energy Corporation Limited

HOLD

Current Price

$2.61

Market Cap

47.2M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERU
INDO
Founded
1971
2018
Country
United States
Indonesia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
47.2M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
VERU
INDO
Price
$2.92
$2.61
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
5.2M
677.8K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,296,958.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$2.44
52 Week High
$7.33
$8.50

Technical Indicators

Market Signals
Indicator
VERU
INDO
Relative Strength Index (RSI) 52.97 40.82
Support Level $2.15 N/A
Resistance Level $3.68 $3.02
Average True Range (ATR) 0.67 0.15
MACD -0.01 -0.00
Stochastic Oscillator 15.52 29.66

Price Performance

Historical Comparison
VERU
INDO

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About INDO Indonesia Energy Corporation Limited

Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.

Share on Social Networks: